0000352998-21-000009.txt : 20210722
0000352998-21-000009.hdr.sgml : 20210722
20210722162522
ACCESSION NUMBER: 0000352998-21-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210721
FILED AS OF DATE: 20210722
DATE AS OF CHANGE: 20210722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pate R Carter
CENTRAL INDEX KEY: 0001641406
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08568
FILM NUMBER: 211107907
MAIL ADDRESS:
STREET 1: 5739 WORTHAM LANE
CITY: DALLAS
STATE: TX
ZIP: 75252
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teligent, Inc.
CENTRAL INDEX KEY: 0000352998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 010355758
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 LINCOLN AVENUE
CITY: BUENA
STATE: NJ
ZIP: 08310
BUSINESS PHONE: 856.697.1441
MAIL ADDRESS:
STREET 1: 105 LINCOLN AVENUE
CITY: BUENA
STATE: NJ
ZIP: 08310
FORMER COMPANY:
FORMER CONFORMED NAME: IGI LABORATORIES, INC
DATE OF NAME CHANGE: 20100408
FORMER COMPANY:
FORMER CONFORMED NAME: IGI INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOGENETICS INC
DATE OF NAME CHANGE: 19870814
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-07-21
0
0000352998
Teligent, Inc.
TLGT
0001641406
Pate R Carter
C/O TELIGENT, INC.
105 LINCOLN AVENUE
BUENA
NJ
08310
1
0
0
0
Restricted Stock Units
2021-07-21
4
A
0
150000
0
A
2022-07-21
Common Stock
150000
150000
D
Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.
The shares underlying the derivative securities shall vest fully on the first anniversary of grant.
Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50.
/s/ R. Carter Pate
2021-07-22